Background: Perioperative nutrition modulation of gut microbiota is increasingly used as a strategy for reducing the infective complications of elective surgery. This meta-analysis assessed the effect of probiotic and synbiotic preparations on the incidence of postoperative sepsis. Methods: Randomized controlled trials that compared preoperative dosing of probiotics and synbiotics in patients undergoing elective general surgical procedures were included. The primary outcome measure was the postoperative sepsis rate. Pooled outcome measures were determined using random effects models. Results: Thirteen randomized controlled trials totaling 962 patients were included in this analysis (304 received synbiotics and 182 received probiotics). The incidence of postoperative sepsis was reduced in the probiotic group vs the control (pooled odds ratio [OR] = 0.42; 95% confidence interval [CI], 0.23–0.75; P = .003) and in the synbiotic group vs the control (pooled OR = 0.25; 95% CI, 0.1–0.6; P = .002). However, subgroup analysis failed to identify a significant reduction in the incidence of pneumonia, urinary tract infections, or wound infections in the postoperative phase for either treatment group. Synbiotics reduced the length of postoperative antibiotic use (weighted mean differences = −1.71; 95% CI, –3.2 to –0.21; P = .03). Conclusion: Probiotic and synbiotic nutrition strategies reduce the incidence of postoperative sepsis in the elective general surgery setting. These effects appear more pronounced with the use of synbiotics. High-powered, mechanistic studies are now required for the optimization of pro- and prebiotic regimens to further improve their efficacy.
LeaphartCLTepasJJIII. The gut is a motor of organ system dysfunction. Surgery. 2007;141(5):563-569.
2.
GillSRPopMDeboyRT. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355-1359.
3.
WikoffWRAnforaATLiuJ. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A. 2009;106(10):3698-3703.
4.
LederbergJ. Infectious history. Science. 2000;288(5464):287-293.
5.
HartmanALLoughDMBarupalDK. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc Natl Acad Sci U S A. 2009;106(40):17187-17192.
6.
ZhangHDiBaiseJKZuccoloA. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106(7):2365-2370.
7.
KinrossJMAlkhamesiNBartonRH. Global metabolic phenotyping in an experimental laparotomy model of surgical trauma. J Proteome Res. 2010;10:277-287.
8.
WhelanKJuddPATuohyKMGibsonGRPreedyVRTaylorMA. Fecal microbiota in patients receiving enteral feeding are highly variable and may be altered in those who develop diarrhea. Am J Clin Nutr. 2009;89(1):240-247.
9.
MaiVGreenwaldBMorrisJGJrRaufmanJPStineOC. Effect of bowel preparation and colonoscopy on post-procedure intestinal microbiota composition. Gut. 2006;55(12):1822-1823.
10.
JakobssonHEJernbergCAnderssonAFSjolund-KarlssonMJanssonJKEngstrandL. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE. 2010;5(3):e9836.
11.
VesperBJJawdiAAltmanKWHainesGK3rdTaoLRadosevichJA. The effect of proton pump inhibitors on the human microbiota. Curr Drug Metab. 2009;10(1):84-89.
12.
RollerMRechkemmerGWatzlB. Prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis modulates intestinal immune functions in rats. J Nutr. 2004;134(1):153-156.
13.
WoodardGAEncarnacionBDowneyJR. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13(7):1198-1204.
14.
ReddyBSMacfieJGattMLarsenCNJensenSSLeserTD. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg. 2007;94(5):546-554.
15.
SchrezenmeirJde VreseM. Probiotics, prebiotics, and synbiotics—approaching a definition. Am J Clin Nutr. 2001;73(2)(suppl):361S-364S.
16.
GibsonGRRoberfroidMB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125(6):1401-1412.
17.
RijkersGTde VosWMBrummerRJMorelliLCorthierGMarteauP. Health benefits and health claims of probiotics: bridging science and marketing. Br J Nutr. 2011;106(9):1291-1296.
18.
GibsonGRMcCartneyALRastallRA. Prebiotics and resistance to gastrointestinal infections. Br J Nutr. 2005;93(suppl 1):S31-S34.
19.
TuohyKMRouzaudGCBruckWMGibsonGR. Modulation of the human gut microflora towards improved health using prebiotics—assessment of efficacy. Curr Pharm Design. 2005;11(1):75-90.
20.
AureliPCapursoLCastellazziAM. Probiotics and health: an evidence-based review. Pharm Res. 2011;63(5):366-376.
21.
MihatschWABraeggerCPDecsiT. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr. 2012;31(1):6-15.
22.
SiemposIINtaidouTKFalagasME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med. 2010;38(3):954-962.
23.
ZhangMMChengJQLuYRYiZHYangPWuXT. Use of pre-, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis. World J Gastroenterol. 2010;16(31):3970-3978.
24.
BesselinkMGvan SantvoortHCRenooijW. Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg. 2009;250(5):712-719.
25.
NomuraTTsuchiyaYNashimotoA. Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology. 2007;54(75):661-663.
26.
GurusamyKSKumarYDavidsonBR. Methods of preventing bacterial sepsis and wound complications for liver transplantation. Cochrane Database Syst Rev. 2008;(4):CD006660.
27.
UsamiMMiyoshiMKanbaraY. Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. JPEN J Parenter Enteral Nutr. 2011;35(3):317-328.
28.
WoodardGAEncarnacionBDowneyJR. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13(7):1198-1204.
29.
LandMHRouster-StevensKWoodsCRCannonMLCnotaJShettyAK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005;115(1):178-181.
30.
RayesNSeehoferDNeuhausP. Prebiotics, probiotics, synbiotics in surgery—are they only trendy, truly effective or even dangerous?Langenbecks Arch Surg. 2009;394(3):547-555.
31.
WatkinsonPJBarberVSDarkPYoungJD. The use of pre-, pro- and synbiotics in adult intensive care unit patients: systematic review. Clin Nutr. 2007;26(2):182-192.
32.
PitsouniEAlexiouVSaridakisVPeppasGFalagasME. Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2009;65(6):561-570.
33.
BrownawellAMCaersWGibsonGR. Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J Nutr. 2012;142(5):962-974.
34.
DellingerRPCarletJMMasurH. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858-873.
35.
DerSimonianR. Meta-analysis in the design and monitoring of clinical trials. Stat Med. 1996;15(12):1237-1248; discussion 1249-1252.
36.
EguchiSTakatsukiMHidakaMSoyamaAIchikawaTKanematsuT. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg. 2011;201(4):498-502.
37.
DiepenhorstGMvan RulerOBesselinkMG. Influence of prophylactic probiotics and selective decontamination on bacterial translocation in patients undergoing pancreatic surgery: a randomized controlled trial. Shock. 2011;35(1):9-16.
38.
HorvatMKrebsBPotrcSIvaneczAKompanL. Preoperative synbiotic bowel conditioning for elective colorectal surgery. Wien Klin Wochenschr. 2010;122(suppl 2):26-30.
39.
AndersonADMcNaughtCEJainPKMacFieJ. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut. 2004;53(2):241-245.
40.
KanazawaHNaginoMKamiyaS. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg. 2005;390(2):104-113.
41.
LiuZQinHYangZ. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery—a double-blind study. Aliment Pharmacol Ther. 2011;33(1):50-63.
42.
McNaughtCEWoodcockNPMacFieJMitchellCJ. A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut. 2002;51(6):827-831.
43.
RayesNSeehoferDTheruvathT. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant. 2005;5(1):125-130.
44.
RayesNSeehoferDTheruvathT. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg. 2007;246(1):36-41.
45.
RayesNHansenSSeehoferD. Early enteral supply of fiber and lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition. 2002;18(7-8):609-615.
46.
RayesNSeehoferDHansenS. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2002;74(1):123-127.
47.
GianottiLMorelliLGalbiatiF. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol. 2010;16(2):167-175.
48.
Van GossumADewitOLouisE. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn’s disease after lleo-caecal resection. Inflamm Bowel Dis. 2007;13(2):135-142.
49.
SugawaraGNaginoMNishioH. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244(5):706-714.
50.
RayesNSeehoferDTheruvathT. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg. 2007;246(1):36-41.
51.
SilkDBDavisAVulevicJTzortzisGGibsonGR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29(5):508-518.
52.
DepeintFTzortzisGVulevicJI’AnsonKGibsonGR. Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr. 2008;87(3):785-791.
53.
McCarthyJO’MahonyLO’CallaghanL. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut. 2003;52(7):975-980.
54.
DukeKMurphySSmithM. Probiotic performance in IBD is not uniform: a multi-strain comparison in the lymphocyte transfer model of enterocolitis. Gastroenterology. 2004;126:A283-A284.
55.
O’MahonyDSheilBMacSharryJ. Mechanism of probioti/commensal mediated protection against invasive salmonella infection. Gastroenterology. 2004;126:A516.
56.
VulevicJDrakoularakouAYaqoobPTzortzisGGibsonGR. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr. 2008;88(5):1438-1446.
57.
DrakoularakouATzortzisGRastallRAGibsonGR. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers’ diarrhoea. Eur J Clin Nutr. 2010;64(2):146-152.
58.
McNaughtCEWoodcockNPAndersonADMacFieJ. A prospective randomised trial of probiotics in critically ill patients. Clin Nutr. 2005;24(2):211-219.
RijkersGTBengmarkSEnckP. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr. 2010;140(3):671S-676S.
61.
O’MayGAReynoldsNMacfarlaneGT. Effect of pH on an in vitro model of gastric microbiota in enteral nutrition patients. Appl Environ Microbiol. 2005;71(8):4777-4783.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
